Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

  1. Coombes, R.
  2. Kilburn, L.
  3. Snowdon, C.
  4. Paridaens, R.
  5. Coleman, R.
  6. Jones, S.
  7. Jassem, J.
  8. Van de Velde, C.
  9. Delozier, T.
  10. Alvarez, I.
  11. Del Mastro, L.
  12. Ortmann, O.
  13. Diedrich, K.
  14. Coates, A.
  15. Bajetta, E.
  16. Holmberg, S.
  17. Dodwell, D.
  18. Mickiewicz, E.
  19. Andersen, J.
  20. Lønning, P.
  21. Cocconi, G.
  22. Forbes, J.
  23. Castiglione, M.
  24. Stuart, N.
  25. Stewart, A.
  26. Fallowfield, L.
  27. Bertelli, G.
  28. Hall, E.
  29. Bogle, R.
  30. Carpentieri, M.
  31. Colajori, E.
  32. Subar, M.
  33. Ireland, E.
  34. Bliss, J.
  35. Show all authors +
Journal:
Lancet

ISSN: 0140-6736

Year of publication: 2007

Volume: 369

Issue: 9561

Pages: 559-570

Type: Article

DOI: 10.1016/S0140-6736(07)60200-1 GOOGLE SCHOLAR

Sustainable development goals